Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-22-000014
Filing Date
2022-03-31
Accepted
2022-03-31 16:55:56
Documents
72
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K awh-20211231x10k.htm   iXBRL 10-K 3200853
2 EX-4.7 awh-20211231xex4_7.htm EX-4.7 39233
3 EX-21.0 awh-20211231xex21_0.htm EX-21.0 8449
4 EX-23.1 awh-20211231xex23_1.htm EX-23.1 5152
5 EX-31.1 awh-20211231xex31_1.htm EX-31.1 22769
6 EX-31.2 awh-20211231xex31_2.htm EX-31.2 22763
7 EX-32.1 awh-20211231xex32_1.htm EX-32.1 13720
  Complete submission text file 0000926617-22-000014.txt   7232759

Data Files

Seq Description Document Type Size
8 EX-101.SCH awh-20211231.xsd EX-101.SCH 44538
9 EX-101.CAL awh-20211231_cal.xml EX-101.CAL 61607
10 EX-101.DEF awh-20211231_def.xml EX-101.DEF 174640
11 EX-101.LAB awh-20211231_lab.xml EX-101.LAB 430176
12 EX-101.PRE awh-20211231_pre.xml EX-101.PRE 376168
66 EXTRACTED XBRL INSTANCE DOCUMENT awh-20211231x10k_htm.xml XML 349967
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 22793691
SIC: 2835 In Vitro & In Vivo Diagnostic Substances